Volkmann M - Search Results

1

In vitro experimental infection of primary human hepatocytes with hepatitis B virus.

Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H. Galle PR, et al. Among authors: volkmann m. Gastroenterology. 1994 Mar;106(3):664-73. doi: 10.1016/0016-5085(94)90700-5. Gastroenterology. 1994. PMID: 8119538

2

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.

Volkmann M, Müller M, Hofmann WJ, Meyer M, Hagelstein J, Räth U, Kommerell B, Zentgraf H, Galle PR. Volkmann M, et al. Hepatology. 1993 Sep;18(3):559-65. Hepatology. 1993. PMID: 7689531

3

p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H, Galle PR. Volkmann M, et al. Oncogene. 1994 Jan;9(1):195-204. Oncogene. 1994. PMID: 8302580

4

Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma.

Volkmann M, Schiff JH, Hajjar Y, Otto G, Stilgenbauer F, Fiehn W, Galle PR, Hofmann WJ. Volkmann M, et al. J Mol Med (Berl). 2001 Oct;79(10):594-600. doi: 10.1007/s001090100244. J Mol Med (Berl). 2001. PMID: 11692157

5

Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.

Müller M, Meyer M, Schilling T, Ulsperger E, Lehnert T, Zentgraf H, Stremmel W, Volkmann M, Galle PR. Müller M, et al. Among authors: volkmann m. Int J Oncol. 2006 Oct;29(4):973-80. Int J Oncol. 2006. PMID: 16964393

6

Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis.

Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, Wesch H, Mariani SM, Hack V, Stremmel W, Krammer PH, Galle PR. Strand S, et al. Among authors: volkmann m. Nat Med. 1998 May;4(5):588-93. doi: 10.1038/nm0598-588. Nat Med. 1998. PMID: 9585233

7

Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.

Seelig HP, Appelhans H, Bauer O, Blüthner M, Hartung K, Schranz P, Schultze D, Seelig CA, Volkmann M. Seelig HP, et al. Among authors: volkmann m. Clin Lab. 2011;57(9-10):753-65. Clin Lab. 2011. PMID: 22029192

8

Clinical implications of the p53 tumor-suppressor gene.

Müller M, Volkmann M, Zentgraf H, Galle PR. Müller M, et al. Among authors: volkmann m. N Engl J Med. 1994 Mar 24;330(12):865. N Engl J Med. 1994. PMID: 8166834 No abstract available.

9

Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.

Ryder SD, Rizzi PM, Volkmann M, Metivier E, Pereira LM, Galle PR, Naoumov NV, Zentgraf H, Williams R. Ryder SD, et al. Among authors: volkmann m. J Clin Pathol. 1996 Apr;49(4):295-9. doi: 10.1136/jcp.49.4.295. J Clin Pathol. 1996. PMID: 8655704 Free PMC article.

10

Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression.

Volkmann M, Sinn HP, Gaugel D, Frey M, Hajjar Y, Ludwig J, Hänsel S, Bastert G, Wallwiener D, Fiehn W, Zentgraf H, Huober J. Volkmann M, et al. Oncology. 2002;63(3):297-305. doi: 10.1159/000065472. Oncology. 2002. PMID: 12381910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters